Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
John C. O’Leary(University of South Florida), Chad A. Dickey(University of South Florida), Jeffrey R. Jones(University of South Florida), Paul S. Marinec(University of Michigan), Clara Kraft(University of South Florida), Erin E. Congdon(Neurosciences Institute), Laura J. Blair(University of South Florida), Qingyou Li(University of South Florida), Jason E. Gestwicki(University of California, San Francisco), John Koren(University of Florida), Melinda Peters(USF Health Byrd Alzheimer's Institute), Amelia G. Johnson(University of South Florida), Umesh K. Jinwal(University of South Florida), Jose F. Abisambra(Allen Institute for Brain Science), Edwin J. Weeber(Society for Neuroscience), Karen Duff(UK Dementia Research Institute)
Cited by 176
Related Papers
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
|Nature|2006|2.1k
Primary age-related tauopathy (PART): a common pathology associated with human aging
|Acta Neuropathologica|2014|1.5k
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration<i>in vivo</i>
|Proceedings of the National Academy of Sciences|2005|693
CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity
|Journal of Neuroscience|2011|633